Last reviewed · How we verify
NCT06831656
TetraSOD® Supplementation and Exercise Performance
NA trial testing Placebo-Pre in Placebo-Pre in 15 participants. Completed in 19 May 2021.
19 May 2021
Quick facts
| Lead sponsor | Loughborough University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | double |
| Primary purpose | basic science |
| Enrollment | 15 |
| Start date | 4 October 2019 |
| Primary completion | 19 May 2021 |
| Estimated completion | 19 May 2021 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- Placebo-Pre
- Placebo-Post
- Tetraselmis chuii-Pre
- Tetraselmis chuii-Post
Conditions studied
- Placebo-Pre — all drugs for Placebo-Pre →
- Placebo-Post — all drugs for Placebo-Post →
- Tetraselmis Chuii-Pre — all drugs for Tetraselmis Chuii-Pre →
- Tetraselmis Chuii-Post — all drugs for Tetraselmis Chuii-Post →
Sponsor
Loughborough University
Who can join
Adults 18 to 40, male only, with Placebo-Pre or Placebo-Post. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Tetraselmis chuii (TetraSOD) is a marine microalgae that has been reported to improve antioxidant responses in human skeletal muscle cells treated with TetraSOD and to improve recovery from muscle damaging exercise in humans supplemented with TetraSOD. However, the effects of TetraSOD supplementation on endurance performance and physiology is less clear. This study assessed the effect of short-term TetraSOD supplementation on endurance performance and physiology in healthy adults.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
<i>Tetraselmis chuii</i> Supplementation Increases Skeletal Muscle Nuclear Factor Erythroid 2-Related Factor 2 and Antioxidant Enzyme Gene Expression, and Peak Oxygen Uptake in Healthy Adults: A Randomised Crossover Trial.
Cocksedge SP, Infante C, Torres S, Lama C, et al · · 2025 · PMID 40298824 · DOI 10.3390/antiox14040435
Verify or expand the search:
- PubMed search for NCT06831656
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Loughborough University trials
Trials by the same sponsor.
- NCT07510113 — Probiotic Study in Alcohol Recovery · NA · active not recruiting
- NCT07504952 — Investigating the Impact of Probiotics on Wellbeing in a Community · NA · completed
- NCT06682897 — Simplified Tai Chi Exercises to Improve Function in People With Chronic Ankle Instability · NA · completed
- NCT06669702 — EXercise Therapy in Axial SpA, Inflammation and Biologic Therapy (ExTASI-B) · NA · recruiting
- NCT06849050 — The Influence of Acute Continuous Exercise and Adiposity on Appetite Hormones and Neural Correlates of Visual Food Cues · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06831656 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Loughborough University
- Last refreshed: 18 February 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06831656.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing